Circut2_edited.png

ABOUT US

MANAGEMENT

ben-pless-headshot-3.jpg

BEN PLESS, CEO, FOUNDER, DIRECTOR

Over 25 years experience in medical device development and leadership at multi-

national and start-up companies, including Ventritex, St. Jude Medica, NeuroPace

and Autonomic Technologies. MIT graduate, inventor of over 140 patents.

ben-pless-headshot-3.jpg
Craig-Patterson-(1).jpg

CRAIG PATTERSON, CFO, VICE PRESIDENT BUSINESS DEVELOPMENT

Over 20+ years experience in medical devices, including 7 years international 

(Europe). Raised over $70M of private equity/debt. Worked in multi-national

companies as well as start-ups including Autonomic Technologies.

ben-pless-headshot-3.jpg
Screen Shot 2022-01-06 at 5.05.57 PM.png

DAN BACHER, VICE PRESIDENT R&D

Over 10 years in engineering and program management in the medical device 

industry, including implanted neurological devices and products ranging from

hand-held drug delivery systems to minimally invasive surgical robotics.

image001_edited.jpg

SHANNON SCHUETZ, SR. DIR. OF OPERATIONS

 

Over 15 years of experience in the commercialization of medical devices including

intellectual property, technical, market and contracting analysis and strategy.

Worked at Avation Medical, Autonomic Technologies and Cleveland Clinic

Innovations/New Ventures.

ADVISORS

Langer_edited.jpg

ROBERT LANGER, PHD, FOUNDER

David H. Koch Institute Professor at Massachusetts Institute of Technology,

prolific inventor and most cited engineer in history.

Screenshot 2022-01-06 at 17-06-13 Company ΓÇö Celero Systems.png

JEREMY RUSKIN, MD, FOUNDER

World-renowned cardiologist and electrophysiologist. Founder and Director

Emeritus of the Cardiac Arrhythmia Service at Massachusetts General Hospital

and Professor of Medicine at Harvard Medical School.

Screenshot 2022-01-06 at 17-06-22 Company ΓÇö Celero Systems.png

GIOVANNI TRAVERSO, MD, PHD FOUNDER, DIRECTOR

Gastroenterologist and biomedical engineer. Assistant Professor in the Department

of Mechanical Engineering, Massachusetts Institute of Technology, and at Brigham

and Women's Hospital, Harvard Medical School. Current research focused on

developing the next generation of drug delivery systems to enable safe and efficient 

delivery of therapeutics through the gastrointestinal tract, as well as developing

novel ingestible electronic devices for sensing a broad array of physiologic and 

pathophysiologic parameters.

PkVNhbCa_400x400.jpg

ALI REZAI, MD, SENIOR SCIENCE ADVISOR 

Executive Chair, VP of Neuroscience and John D. Rockefeller IV.

Tenured Professor in Neuroscience at West Virginia University.

CLINICAL ADVISORS
PAIN AND ADDICTION MEDICINE SPECIALISTS

Yeshvant-A.-Navalgund-Professional-Headshot.1).1)-min.jpg

YEASHVANT NAVALGUND, MD 

Assistant Professor, Dept of Anesthesiology/Division of Pain Management at West Virginia University. Founder, Former President of the Pennsylvania Pain Society. Founder of DNAPAIN clinics.

Untitled-2.png

DAN CICCARONE, MD 

Professor, Family Community Medicine at the University of California, San Francisco. Author and advocate for CDC Naloxone co-prescribing with high-dose opioids policy.

61856bb80c3b6.image.jpg

JAMES BERRY, DO 

Chair, Department of Behavioral Medicine & Psychiatry. Director, Addiction Services and Medical Director, J.W. Ruby Memorial Hospital at West Virginia University.

PARTNERS

Technology licensed from Mass General Brigham and its affiliates and Massachusetts Institute of Technology to enhance CELERO System’s technology platform.

BRIGHAM+LOGO.png
MIT+LOGO.png
MGH+LOGO.png
PARTNERS+HC+LOGO.png